TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
Global drug sales Top100 in the first quarter of 2017
 
Author:中国铭铉 企划部  Release Time:2017-6-7 10:16:51  Number Browse:510
 
The results of the first quarter of the pharmaceutical company's first quarter have been announced. Here's a look at some of the world's drug sales for the first quarter of 2017. 
 
Abbvie's Humria continues to top the list with a big advantage. Gilead Harvoni hepatitis c drug sales fell more, just keep the position in the first 10, but the new anti HCV drugs Epclusa sales reached $892 million in the first quarter, is one of the most popular drug list to go forward. In addition, the drugs with increased sales are also known as the BMS anticoagulants Eliquis, novartis's psoriasis mono-antidrug secukinumab, GSK's anti-hiv drug Tivicay and BMS's ctla-4 inhibitor Yervoy. 
 
Global drug sales Top100 in the first quarter of 2017 
 
 
Note: the red font is the predicted value 
 
Data source: company report 
 
Previous article:The three sectors of net profit, TOP3, were revealed
Next article:Look at the opportunities for the enterprise of the heavy drug belt in the urinary system
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粤公网安备 44011202000029号